Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
ClinicalTrials.gov study NCT00918333. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment.
ClinicalTrials.gov study NCT00967369. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
ClinicalTrials.gov study NCT01030900. IPD Sharing: YES. Countries: 1. Publications: 0.
Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
ClinicalTrials.gov study NCT00868608. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00516217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT05685173. IPD Sharing: YES. Countries: 5. Publications: 0.
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT00574496. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT01329900. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00384111. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
ClinicalTrials.gov study NCT01014507. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00478062. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma
ClinicalTrials.gov study NCT00654732. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT03120676. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT01073163. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00088881. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma
ClinicalTrials.gov study NCT04788043. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT02568683. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05255601. IPD Sharing: Not stated. Countries: 8. Publications: 0.
A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03009344. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00053027. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.